Results 151 to 160 of about 10,981 (164)

Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathies

BMC Nephrology, 2009
Guy Rostoker
exaly  

Managing Diabetic Nephropathies in Clinical Practice

2017
George L Bakris, Daisuke Koya, Mark E Molitch   +2 more
exaly  

Diverse Effects of Increasing Lisinopril Doses on Lipid Abnormalities in Chronic Nephropathies

Circulation, 2003
Piero Ruggenenti, Annalisa Perna, Dario Cattaneo   +2 more
exaly  

Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies

Kidney International, 2003
Fabio Sangalli, Annalisa Perna, Andrea Remuzzi   +2 more
exaly  

Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies?

Nephrology Dialysis Transplantation, 2006
Henri Boulanger, Denis Glotz
exaly  

The verapamil versus amlodipine in nondiabetic nephropathies treated with trandolapril (VVANNTT) study

American Journal of Kidney Diseases, 2003
Giacomo Lanfranco, F Quarello
exaly  

Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies

American Journal of Physiology - Renal Physiology, 2002
Roberto Zatz, Clarice Kazue Fujihara
exaly  

Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury

American Journal of Kidney Diseases, 2000
Piero Ruggenenti, Annalisa Perna, Giulia Gherardi   +2 more
exaly  

Managing Diabetic Nephropathies in Clinical Practice: Emerging and Future Therapies

2017
George L Bakris, Bakris George
exaly  

Non-Diabetic Nephropathies among Diabetic Patients of the Nephrology Department of Dakar

Open Journal of Nephrology, 2019
exaly